24 results on '"Van den Hauwe M"'
Search Results
2. Idebenone reduces respiratory complications in patients with Duchenne muscular dystrophy
3. Hammersmith Functional Motor Scale and Motor Function Measure-20 in non ambulant SMA patients
4. Gait stage classification for children with Duchenne muscular dystrophy based on longitudinal follow-up of progressive gait pathology
5. Six minute walk test in type III spinal muscular atrophy: A 12 month longitudinal study
6. Instrumented strength assessment in typically developing children and children with a neural or neuromuscular disorder: Reliability, validity and responsiveness
7. P.2 - The association between muscle weakness and gait deviations in children with Duchenne muscular dystrophy
8. P.322 - Normative data and reference equation for the six-minute walk test in healthy Caucasian boys aged 13–18 years
9. G.P.144 - Reference values for the three-minute walk test, North Star ambulatory assessment and timed tests in typically developing boys aged 2.5–5 years
10. G.P.145 - Assessment of early motor development in young boys with Duchenne muscular dystrophy
11. G.P.139 - Development of a patient-reported outcome measure for arm and hand function in Duchenne muscular dystrophy (UL-PROM DMD)
12. S.P.9 Development of an upper limb functional scale in dystrophinopathies
13. S.P.2 Disease progression as measured by the 6MWD in Duchenne Muscular Dystrophy; a single centre experience of 62 boys treated with daily corticosteroids
14. Longitudinal alterations of gait features in growing boys with Duchenne muscular dystrophy.
15. P4.27 Fourty eight-week follow-up data from a Phase I/IIa extension study of systemic PRO051/GSK2402968 in Duchenne muscular dystrophy: Comparison with contemporaneous controls for 6-min walking distance test
16. P4.8 Results from a two-year open label intervention study with idebenone (Catena®) in Duchenne muscular dystrophy
17. T.P.3.01 Glucocorticoids influence therapeutic efficacy of idebenone (Catena®) on peak expiratory flow in patients with Duchenne muscular dystrophy (DMD)
18. M.P.3.01 Gait steadiness and upper-body kinematics in DMD children
19. M.P.3.02 Detailed analysis of daily-life physical activity patterns in DMD children
20. O50 – 1933 Normative data of the 6-minute walk test in healthy boys aged 5–12 years and correlations with anthropometric variables and myometry.
21. Gait stage classification of children with Duchenne muscular dystrophy.
22. T.P.3.01 Glucocorticoids influence therapeutic efficacy of idebenone (Catena®) on peak expiratory flow in patients with Duchenne muscular dystrophy (DMD)
23. P.468 - Are muscle volume and echo-intensity related to rate of force development in children with Duchenne muscular dystrophy?
24. G.P.10 07 CINRG pilot trial of oxatomide in steroid-naive Duchenne muscular dystrophy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.